Are Shalby Ltd. latest results good or bad?

Feb 12 2026 08:03 PM IST
share
Share Via
Shalby Ltd.'s latest Q3 FY26 results are concerning, showing a 4.66% decline in net sales and a 78.90% drop in net profit, indicating significant operational challenges and deteriorating profitability metrics. The company's financial health is further compromised by rising leverage and low returns on equity and capital employed.
Shalby Ltd.'s latest financial results for Q3 FY26 reveal significant operational challenges and a concerning decline in profitability metrics. The company reported net sales of ₹272.13 crores, which reflects a quarter-on-quarter decrease of 4.66% and a year-on-year contraction of 1.27%. This marks the second consecutive quarter of revenue decline, indicating weak operational momentum in a sector that is generally experiencing growth.
The net profit for the quarter was ₹1.77 crores, down sharply by 78.90% from the previous quarter. While there was a year-on-year increase in net profit of 197.79% compared to a negative base in Q3 FY25, the sequential decline raises red flags regarding the sustainability of profitability. The profit after tax margin fell to just 0.47%, down from 2.55% in the previous quarter, highlighting severe operational stress. Operating margins, excluding other income, also saw a significant compression, dropping to 11.12% from 14.58% in Q2 FY26. This decline suggests rising cost pressures and operational inefficiencies that the company has struggled to address. The reliance on non-operating income, which constituted a substantial portion of profit before tax, further obscures the underlying operational weaknesses. Additionally, Shalby's return on equity (ROE) has deteriorated to 0.45%, and return on capital employed (ROCE) has weakened to 5.00%. These figures are among the lowest in the hospital sector, indicating that the company is generating minimal returns relative to the equity capital deployed. The company's balance sheet reflects rising leverage, with a debt-to-equity ratio of 0.53 times, the highest in recent periods. This increase in debt, coupled with declining profitability, raises concerns about financial flexibility and sustainability. Investor sentiment appears cautious, as evidenced by the stock's significant underperformance relative to the broader hospital sector, which has been delivering robust growth. The company has seen an adjustment in its evaluation, reflecting the market's recognition of these deteriorating fundamentals. In summary, Shalby Ltd.'s Q3 FY26 results indicate a troubling deterioration in operational efficiency, profitability, and capital returns, raising concerns about the company's ability to navigate the current market environment effectively.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News